COMP <GO>
AHCO vs JNJ // GROSS PROFIT MARGIN
AdaptHealth Corp. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: AHCO 1
— JNJ 9
▲ GROSS PROFIT MARGIN LEADER: JNJ
LAST: $5.93 (-1.66%) • MKT CAP: $808.5M
gross-margins
18.80%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHCO VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AHCO | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 18.80% | 67.90% | -49.10 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.20% | 25.50% | -23.30 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | 18.5x | -12.40 | AHCO | /valuation <GO> |
| Free Cash Flow Yield | — | 2.97% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 2.80% | 34.70% | -31.90 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -2.20% | 28.50% | -30.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -0.50% | 6.00% | -6.50 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.79 | 5.59 | -4.80 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.2 | 62.1 | -17.87 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $808.5M | $662.49B | -$661.68B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AHCO REV | JNJ REV | AHCO GROSS % | JNJ GROSS % | AHCO FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.24B | $94.19B | 18.8% | 67.9% | $219.4M | $19.70B |
| FY 2024 | $3.26B | $88.82B | 20.9% | 69.1% | $235.8M | $19.84B |
| FY 2023 | $3.20B | $85.16B | — | — | $480.7M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHCO // BETA —
JNJ // BETA 1.08